- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Paraproteinemias in New Zealand
Total 850 results
-
Alaunos TherapeuticsCompleted
-
Alliance Foundation Trials, LLC.Takeda; Janssen Scientific Affairs, LLC; Celgene CorporationActive, not recruitingMyeloma, MultipleUnited States
-
Juno Therapeutics, Inc., a Bristol-Myers Squibb...RecruitingMultiple MyelomaUnited States, Canada
-
Genzyme, a Sanofi CompanyCompletedMultiple MyelomaUnited States, Canada, Germany
-
CelgeneCompletedMultiple Myeloma | Renal ImpairmentUnited States, Canada
-
Calithera Biosciences, IncCompletedMultiple Myeloma | Non-Hodgkin's Lymphoma (NHL) | Waldenstrom's Macroglobulinemia (WM) | Other B-cell NHL Subtypes, Including WM | T-cell NHLUnited States
-
AmgenTerminatedRelapsed and/or Refractory Multiple MyelomaUnited States, Japan, Belgium, Australia, Switzerland
-
OnxeoCompletedMultiple MyelomaUnited States, Denmark, United Kingdom, Norway
-
Regeneron PharmaceuticalsActive, not recruitingRefractory Multiple Myeloma | Relapsed Multiple MyelomaUnited States
-
K36 Therapeutics, Inc.RecruitingMultiple Myeloma | Myeloma | Myeloma MultipleUnited States, France, Spain, Canada
-
ImmunoGen, Inc.Completed
-
Jonsson Comprehensive Cancer CenterGenentech, Inc.Completed
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)RecruitingRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
TakedaActive, not recruiting
-
Horizon Health NetworkActive, not recruiting
-
CephalonTerminatedMultiple MyelomaUnited States
-
Celgene CorporationPrologue Research InternationalCompletedMultiple MyelomaUnited States, Canada
-
National Cancer Institute (NCI)Recruiting
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedMultiple Myeloma | Plasma Cell NeoplasmUnited States
-
Novartis PharmaceuticalsCompleted
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedLymphomaUnited States, Canada, United Kingdom, Sweden
-
AmgenCompletedMultiple MyelomaCanada, Denmark, Finland, France, Italy, Spain, Sweden, United Kingdom, Czechia, Poland, United States, Belgium, Hungary, New Zealand, Australia, Germany, Japan, Greece, Norway, Romania
-
University of Medicine and Dentistry of New JerseyNational Cancer Institute (NCI)TerminatedLymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Multiple Myeloma and Plasma Cell Neoplasm | Myelodysplastic/Myeloproliferative Diseases | Precancerous/Nonmalignant ConditionUnited States
-
University of Michigan Rogel Cancer CenterJanssen Scientific Affairs, LLCActive, not recruiting
-
Herbert Irving Comprehensive Cancer CenterNational Cancer Institute (NCI)UnknownLymphoma | Myelodysplastic Syndromes | Leukemia | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
Nerviano Medical SciencesRecruitingMultiple MyelomaUnited States, Italy
-
CelgeneRecruitingMultiple MyelomaUnited States, France, Germany, Spain, United Kingdom, Italy
-
Novartis PharmaceuticalsCompletedSmoldering Multiple MyelomaGermany, United States, France
-
Juno Therapeutics, a Subsidiary of CelgeneActive, not recruitingMultiple MyelomaUnited States
-
Juno Therapeutics, a Subsidiary of CelgeneActive, not recruiting
-
Janssen Scientific Affairs, LLCTerminated
-
CelgeneCompletedMultiple MyelomaUnited States, Canada, Belgium, France, Germany, Italy, Japan, Spain
-
Southwest Oncology GroupNational Cancer Institute (NCI); Eastern Cooperative Oncology Group; Cancer and...CompletedMultiple MyelomaUnited States
-
Jennifer AmengualCompletedLymphoma | Multiple Myeloma | Hodgkin Lymphoma | Lymphoid Malignancies | Non-hodgkin LymphomaUnited States
-
Multiple Myeloma Research FoundationActive, not recruiting
-
AmgenCompletedMultiple Myeloma | Solid TumorsUnited States, Canada
-
iTeos Belgium SABristol-Myers Squibb; GlaxoSmithKline; iTeos TherapeuticsTerminatedMultiple MyelomaUnited States, France, Spain, Belgium
-
Threshold PharmaceuticalsUnknown
-
Memorial Sloan Kettering Cancer CenterMillennium Pharmaceuticals, Inc.CompletedAmyloidosis | Light Chain Deposition Disease (LCDD or MIDD) | Light Chain and Heavy Chain Deposition Disease (LHCDD or MIDD) | Monoclonal Immunoglobulin Deposition Disease (MIDD)United States
-
Janssen-Ortho Inc., CanadaTerminated
-
Washington University School of MedicineMillennium Pharmaceuticals, Inc.; Multiple Myeloma Research ConsortiumActive, not recruiting
-
Alaunos TherapeuticsUnknownMultiple MyelomaUnited States
-
Xcyte TherapiesCompleted
-
University of RochesterCompletedMultiple Myeloma and Plasma Cell Neoplasm | Drug/Agent Toxicity by Tissue/OrganUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedMultiple Myeloma | Acute Lymphoblastic Leukemia | Myelodysplastic Syndrome | Acute Myelogenous LeukemiaUnited States
-
Acerta Pharma BVAstraZenecaActive, not recruitingMultiple Myeloma | Non-Hodgkins Lymphoma | B-AllUnited States
-
BeiGeneNo longer availableWaldenström MacroglobulinemiaUnited States
-
Bristol-Myers SquibbExelixisCompletedAdvanced Cancer, Various, NOSUnited States
-
AbbottM.D. Anderson Cancer Center; Dana-Farber Cancer Institute; Norwood Immunology...TerminatedLymphoma, Non-Hodgkin | Multiple Myeloma | Hodgkin Disease | Mantle Cell LymphomaUnited States
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI); Janssen Scientific Affairs, LLCWithdrawnRecurrent Plasma Cell MyelomaUnited States